Aemetis (AMTX) 10-Q12 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2024	Oct. 31, 2024
Document Information [Line Items]
Entity Central Index Key	0000738214
Entity Registrant Name	AEMETIS, INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-36475
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1407544
Entity Address, Address Line One	20400 Stevens Creek Blvd., Suite 700
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	213-0940
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	AMTX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,734,572

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 296	$ 2,667
Accounts receivable	8,027	8,633
Inventories	19,792	18,291
Prepaid expenses	1,781	3,347
Other current assets	5,004	3,462
Total current assets	34,900	36,400
Property, plant and equipment, net	195,939	195,108
Operating lease right-of-use assets	2,333	2,056
Other assets	14,253	9,842
Total assets	247,425	243,406
Liabilities, Current [Abstract]
Accounts payable	37,254	32,132
Current portion of long term debt	55,797	13,585
Short term borrowings	21,418	23,443
Other current liabilities	17,773	15,229
Total current liabilities	132,242	84,389
Liabilities, Noncurrent [Abstract]
Senior secured notes and revolving notes	164,408	176,476
EB-5 notes	26,000	29,500
Other long term debt	54,583	51,717
Other long term liabilities	5,232	5,112
Total long term liabilities	374,092	375,994
Stockholders' deficit:
Common stock, $0.001 par value; 80,000 authorized; 47,817 and 40,966 shares issued and outstanding each period, respectively	48	41
Additional paid-in capital	293,611	264,058
Accumulated deficit	(546,745)	(475,405)
Accumulated other comprehensive loss	(5,823)	(5,671)
Total stockholders' deficit	(258,909)	(216,977)
Total liabilities and stockholders' deficit	247,425	243,406
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Liabilities, Noncurrent [Abstract]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 123,869	$ 113,189

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Cash and cash equivalents	$ 296	$ 2,667
Accounts receivable	8,027	8,633
Prepaid expenses	1,781	3,347
Other current assets	5,004	3,462
Property, plant and equipment, net	195,939	195,108
Operating lease right-of-use assets	2,333	2,056
Other assets	14,253	9,842
Accounts payable	37,254	32,132
Current portion of long term debt	55,797	13,585
Short term borrowings	21,418	23,443
Other current liabilities	17,773	15,229
Other long term debt	54,583	51,717
Other long term liabilities	$ 5,232	$ 5,112
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized (in shares)	80,000	80,000
Common Stock, Shares Issued (in shares)	47,817	40,966
Common Stock, Shares Outstanding (in shares)	47,817	40,966
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 123,869	$ 113,189
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	0	1,093
Accounts receivable	60	55
Prepaid expenses	164	1,438
Other current assets	2	289
Property, plant and equipment, net	91,468	81,966
Operating lease right-of-use assets	630	145
Other assets	7,024	4,881
Accounts payable	4,725	3,815
Current portion of long term debt	730	190
Short term borrowings	0	9
Other current liabilities	40	48
Other long term debt	45,880	40,857
Other long term liabilities	516	67
Variable Interest Entity, Primary Beneficiary [Member] \| Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent	$ 123,869	$ 113,189

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues	$ 81,441	$ 68,690	$ 220,636	$ 115,953
Cost of goods sold	77,563	68,198	219,176	114,800
Gross profit	3,878	492	1,460	1,153
Selling, general and administrative	7,750	9,021	28,400	29,595
Operating loss	(3,872)	(8,529)	(26,940)	(28,442)
Interest expense
Interest rate expense	10,096	8,749	29,092	24,126
Debt related fees and amortization expense	1,651	1,433	4,892	4,732
Accretion and other expenses of Series A preferred units	3,267	7,739	10,055	20,188
Other income	(1,225)	(1,853)	(1,176)	(2,020)
Loss before income taxes	(17,661)	(24,597)	(69,803)	(75,468)
Income tax expense (benefit)	274	(55,308)	1,537	(54,490)
Net income (loss)	(17,935)	30,711	(71,340)	(20,978)
Other comprehensive income (loss)
Foreign currency translation loss	(116)	(260)	(152)	(127)
Comprehensive income (loss)	$ (18,051)	$ 30,451	$ (71,492)	$ (21,105)
Net income (loss) per common share
Basic (in dollars per share)	$ (0.38)	$ 0.79	$ (1.6)	$ (0.56)
Diluted (in dollars per share)	$ (0.38)	$ 0.73	$ (1.6)	$ (0.56)
Weighted average shares outstanding
Basic (in shares)	47,216	38,881	44,517	37,504
Diluted (in shares)	47,216	41,841	44,517	37,504

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net loss	$ (71,340)	$ (20,978)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation	6,928	6,223
Depreciation	6,121	5,208
Debt related fees and amortization expense	4,892	4,732
Intangibles and other amortization expense	36	35
Accretion and other expenses of Series A preferred units	10,055	20,188
Loss on asset disposals	3,644	0
Gain on debt extinguishment	(162)	0
Warrants issued for working capital agreement	0	409
Deferred tax expense	0	(144)
Changes in operating assets and liabilities:
Accounts receivable	557	(3,344)
Inventories	(1,618)	(3,616)
Prepaid expenses	1,566	2,379
Other assets	(6,930)	(56,797)
Accounts payable	3,481	4,728
Accrued interest expense and fees	20,873	18,483
Other liabilities	1,545	2,356
Net cash used in operating activities	(20,352)	(20,138)
Investing activities:
Capital expenditures	(13,470)	(18,595)
Grant proceeds and other reimbursements received for capital expenditures	3,045	7,682
Net cash used in investing activities	(10,425)	(10,913)
Financing activities:
Proceeds from borrowings	12,534	41,449
Repayments of borrowings	(4,841)	(22,586)
Lender debt renewal and waiver fee payments	(1,445)	(1,681)
Payments on finance leases	(170)	(394)
Proceeds from sales of common stock	21,680	14,767
Proceeds from exercise of stock options	36	45
Net cash provided by financing activities	27,794	31,600
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(4)	117
Net change in cash, cash equivalents, and restricted cash for period	(2,987)	666
Cash, cash equivalents, and restricted cash at beginning of period	6,280	6,999
Cash, cash equivalents and restricted cash at end of period	3,293	7,665
Supplemental disclosures of cash flow information, cash paid:
Cash paid for interest	6,272	6,926
Income taxes paid	878	20
Supplemental disclosures of cash flow information, non-cash transactions:
Subordinated debt extension fees added to debt	680	680
Debt fees added to revolving lines	0	2,236
Fair value of warrants issued to subordinated debt holders	916	1,278
Fair value of warrants issued to lender for debt issuance costs	0	245
Lender debt extension, waiver, and other fees added to debt	695	384
Cumulative capital expenditures in accounts payable, including net increase of $2,160 and $474	$ 10,060	$ 13,459

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows (Unaudited) (Parentheticals) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Increase (decrease) in cumulative capital expenditures in accounts payable	$ 2,160	$ 474

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2022	1,270	35,869
Balance at Dec. 31, 2022	$ 1	$ 36	$ 232,546	$ (428,985)	$ (5,452)	$ (201,854)
Issuance of common stock (in shares)	0	668
Issuance of common stock	$ 0	$ 1	2,616	0	0	2,617
Stock options exercised (in shares)	0	40
Stock options exercised	$ 0	$ 0	0	0	0	0
Stock-based compensation	$ 0	$ 0	2,662	0	0	2,662
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	448	0	0	448
Foreign currency translation loss	0	0	0	0	117	117
Net loss	0	0	0	(26,410)	0	(26,410)
Stock-based compensation	0	0	2,662	0	0	2,662
Foreign currency translation gain	$ 0	$ 0	0	0	117	117
Balance (in shares) at Mar. 31, 2023	1,270	36,690
Balance at Mar. 31, 2023	$ 1	$ 37	238,272	(455,395)	(5,335)	(222,420)
Balance (in shares) at Dec. 31, 2022	1,270	35,869
Balance at Dec. 31, 2022	$ 1	$ 36	232,546	(428,985)	(5,452)	(201,854)
Foreign currency translation loss						(127)
Net loss						(20,978)
Foreign currency translation gain						(127)
Balance (in shares) at Sep. 30, 2023	1,260	39,388
Balance at Sep. 30, 2023	$ 1	$ 39	255,510	(449,963)	(5,579)	(199,992)
Balance (in shares) at Mar. 31, 2023	1,270	36,690
Balance at Mar. 31, 2023	$ 1	$ 37	238,272	(455,395)	(5,335)	(222,420)
Issuance of common stock (in shares)	0	1,353
Issuance of common stock	$ 0	$ 1	6,298	0	0	6,299
Stock options exercised (in shares)	0	72
Stock options exercised	$ 0	$ 0	38	0	0	38
Stock-based compensation	$ 0	$ 0	1,755	0	0	1,755
Issuance and exercise of warrants (in shares)	0	62
Issuance and exercise of warrants	$ 0	$ 0	654	0	0	654
Foreign currency translation loss	0	0	0	0	16	16
Net loss	0	0	0	(25,279)	0	(25,279)
Stock-based compensation	0	0	1,755	0	0	1,755
Foreign currency translation gain	$ 0	$ 0	0	0	16	16
Series B conversion to common stock (in shares)	(10)	1
Series B conversion to common stock	$ 0	$ 0	0	0	0	0
Balance (in shares) at Jun. 30, 2023	1,260	38,178
Balance at Jun. 30, 2023	$ 1	$ 38	247,017	(480,674)	(5,319)	(238,937)
Issuance of common stock (in shares)	0	1,062
Issuance of common stock	$ 0	$ 1	5,850	0	0	5,851
Stock options exercised (in shares)	0	35
Stock options exercised	$ 0	$ 0	7	0	0	7
Stock-based compensation	$ 0	$ 0	1,806	0	0	1,806
Issuance and exercise of warrants (in shares)	0	113
Issuance and exercise of warrants	$ 0	$ 0	830	0	0	830
Foreign currency translation loss	0	0	0	0	(260)	(260)
Net loss	0	0	0	30,711	0	30,711
Stock-based compensation	0	0	1,806	0	0	1,806
Foreign currency translation gain	$ 0	$ 0	0	0	(260)	(260)
Balance (in shares) at Sep. 30, 2023	1,260	39,388
Balance at Sep. 30, 2023	$ 1	$ 39	255,510	(449,963)	(5,579)	(199,992)
Balance (in shares) at Dec. 31, 2023		40,966
Balance at Dec. 31, 2023		$ 41	264,058	(475,405)	(5,671)	(216,977)
Issuance of common stock (in shares)		1,523
Issuance of common stock		$ 2	5,511	0	0	5,513
Stock options exercised (in shares)		14
Stock options exercised		$ 0	36	0	0	36
Stock-based compensation		$ 0	2,969	0	0	2,969
Issuance and exercise of warrants (in shares)		113
Issuance and exercise of warrants		$ 0	593	0	0	593
Foreign currency translation loss		0	0	0	(44)	(44)
Net loss		0	0	(24,231)	0	(24,231)
Stock-based compensation		0	2,969	0	0	2,969
Foreign currency translation gain		$ 0	0	0	(44)	(44)
Balance (in shares) at Mar. 31, 2024		42,616
Balance at Mar. 31, 2024		$ 43	273,167	(499,636)	(5,715)	(232,141)
Balance (in shares) at Dec. 31, 2023		40,966
Balance at Dec. 31, 2023		$ 41	264,058	(475,405)	(5,671)	(216,977)
Foreign currency translation loss						(152)
Net loss						(71,340)
Foreign currency translation gain						(152)
Balance (in shares) at Sep. 30, 2024		47,817
Balance at Sep. 30, 2024		$ 48	293,611	(546,745)	(5,823)	(258,909)
Balance (in shares) at Mar. 31, 2024		42,616
Balance at Mar. 31, 2024		$ 43	273,167	(499,636)	(5,715)	(232,141)
Issuance of common stock (in shares)		3,166
Issuance of common stock		$ 3	10,375	0	0	10,378
Stock-based compensation		0	1,977	0	0	1,977
Foreign currency translation loss		0	0	0	8	8
Net loss		0	0	(29,174)	0	(29,174)
Stock-based compensation		0	1,977	0	0	1,977
Foreign currency translation gain		$ 0	0	0	8	8
Balance (in shares) at Jun. 30, 2024		45,782
Balance at Jun. 30, 2024		$ 46	285,519	(528,810)	(5,707)	(248,952)
Issuance of common stock (in shares)		1,922
Issuance of common stock		$ 2	5,787	0	0	5,789
Stock-based compensation		$ 0	1,982	0	0	1,982
Issuance and exercise of warrants (in shares)		113
Issuance and exercise of warrants		$ 0	323	0	0	323
Foreign currency translation loss		0	0	0	(116)	(116)
Net loss		0	0	(17,935)	0	(17,935)
Stock-based compensation		0	1,982	0	0	1,982
Foreign currency translation gain		$ 0	0	0	(116)	(116)
Balance (in shares) at Sep. 30, 2024		47,817
Balance at Sep. 30, 2024		$ 48	$ 293,611	$ (546,745)	$ (5,823)	$ (258,909)

Note 1 - General

Note 1 - General	9 Months Ended
Note 1 - General	Sep. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	1. General Nature of Activities Founded in 2006 ► California Ethanol 65 ► California Dairy Renewable Natural Gas nine 36 five 48 24 Q1 2025. ► India Biodiesel 60 one In addition, we are actively growing our business by seeking to develop or acquire new facilities, including the following key projects: ► Sustainable Aviation Fuel and Renewable Diesel 90 2023, March 2024, ► Carbon Capture and Underground Sequestration May 2023, first September 2024, 2025 The Company’s current and planned businesses produce renewable fuels and reduce carbon emissions, while generating valuable Renewable Fuel Standard credits, California Low Carbon Fuel Standard credits, and federal tax credits. Basis of Presentation and Consolidation These consolidated financial statements include the accounts of Aemetis, Inc. and its subsidiaries. We consolidate all entities in which we have a controlling financial interest. A controlling financial interest is usually obtained through ownership of a majority of the voting interests. However, an enterprise must consolidate a variable interest entity (“VIE”) if the enterprise is the primary beneficiary of the VIE, even if the enterprise does not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of September 30, 2024 three nine September 30, 2024 2023 nine September 30, 2024 2023 three nine September 30, 2024 2023 December 31, 2023 2023 The consolidated condensed financial statements in this report should be read in conjunction with the 2023 10 December 31, 2023 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three nine September 30, 2024 2023 December 31, 2023 three nine September 30, 2024 not There have been no 1 10 December 31, 2023.

Note 2 - Revenue

Note 2 - Revenue	9 Months Ended
Note 2 - Revenue	Sep. 30, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	2. We derive revenue primarily from sales of ethanol and related co-products in California, renewable natural gas ("RNG") and related environmental attributes in California, and biodiesel and refined glycerin in India. California Ethanol Revenues: Given the similarity of the individual sales transactions with J.D. Heiskell, we have assessed them as a portfolio of similar contracts. The performance obligation is satisfied by delivery of the physical product to our finished goods tank that is leased by J.D. Heiskell. The transaction price is determined based on daily market prices and quarterly contract pricing negotiated by Murex for its customers for ethanol and based on dry distillers' market and local demand by our marketing partner A.L. Gilbert Company (“A.L. Gilbert”) for WDG. The transaction price is allocated to one The following table shows sales in our California Ethanol segment by product category: For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Ethanol sales $ 33,925 $ 36,375 $ 88,748 $ 45,388 Wet distiller's grains sales 8,961 9,427 27,476 11,980 Other sales 2,048 1,637 4,931 1,878 Total $ 44,934 $ 47,439 $ 121,155 $ 59,246 From December 2022 May 2023, nine September 30, 2023. California Dairy Renewable Natural Gas Revenues: September 30, 2024 nine ten 36 "D3 D3 third 2023 first 2024. D3 The following table represents sales in our Renewable Natural Gas segment: For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 RNG, LCFS and D3 RIN sales $ 4,250 $ 1,107 $ 9,640 $ 1,523 India Biodiesel Revenues: The following table shows our sales in our India Biodiesel segment by product category: For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Biodiesel sales $ 31,121 $ 19,291 $ 85,821 $ 53,292 Other sales 1,136 853 4,020 1,892 Total $ 32,257 $ 20,144 $ 89,841 $ 55,184

Note 3 - Cash and Cash Equivale

Note 3 - Cash and Cash Equivalents	9 Months Ended
Note 3 - Cash and Cash Equivalents	Sep. 30, 2024
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	3. The following table reconciles cash, cash equivalents, and restricted cash reported in the consolidated condensed balance sheet to the statement of cash flows: As of September 30, 2024 December 31, 2023 Cash and cash equivalents $ 296 $ 2,667 Restricted cash included in other current assets 115 289 Restricted cash included in other assets 2,882 3,324 Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 3,293 $ 6,280 Restricted cash shown in the table above includes amounts required to be set aside by the Aemetis Biogas 1 2

Note 4 - Basic and Diluted Net

Note 4 - Basic and Diluted Net Income (Loss) Per Share	9 Months Ended
Note 4 - Basic and Diluted Net Income (Loss) Per Share	Sep. 30, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	4. Basic net income (loss) per share is computed by dividing income or loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net income (loss) per share reflects the dilution of common stock equivalents such as options, debt and warrants to the extent the impact is dilutive. The following table shows the number of potentially dilutive shares excluded from the diluted net income (loss) per share calculation as of September 30, 2024 2023 As of September 30, 2024 September 30, 2023 Common stock options and warrants 7,728 3,281 Debt with conversion feature at $ 30 1,151 1,259 Total number of potentially dilutive shares 8,879 4,540

Note 5 - Inventories

Note 5 - Inventories	9 Months Ended
Note 5 - Inventories	Sep. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	5. Inventories Inventories consist of the following: As of September 30, 2024 December 31, 2023 Raw materials $ 10,642 $ 9,907 Work-in-progress 1,591 1,682 Finished goods 7,559 6,702 Total inventories $ 19,792 $ 18,291 As of September 30, 2024 , and December 31, 2023 , the Company recognized a lower of cost or net realizable value adjustment of $2 thousand and $58 thousand, respectively, related to inventory.

Note 6 - Property, Plant and Eq

Note 6 - Property, Plant and Equipment	9 Months Ended
Note 6 - Property, Plant and Equipment	Sep. 30, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	6. Property, Plant and Equipment Property, plant and equipment consist of the following: As of September 30, 2024 December 31, 2023 Land $ 7,341 $ 7,345 Plant and buildings 171,814 136,318 Furniture and fixtures 2,641 2,266 Machinery and equipment 5,695 14,982 Construction in progress 52,978 73,057 Property held for development 15,431 15,431 Finance lease right of use assets 2,889 2,889 Total gross property, plant & equipment 258,789 252,288 Less accumulated depreciation (62,850 ) (57,180 ) Total net property, plant & equipment $ 195,939 $ 195,108 For the three September 30, 2024 2023 not nine September 30, 2024 2023 Construction in progress includes costs for biogas digesters that are under construction, the Riverbank sustainable aviation fuel and renewable diesel plant, the carbon capture and sequestration characterization well, and energy efficiency projects at the Keyes Plant. Property held for development is the partially completed Goodland Plant which is not Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5 For the three September 30, 2024 2023 nine September 30, 2024 2023

Note 7 - Debt

Note 7 - Debt	9 Months Ended
Note 7 - Debt	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	7. Debt Debt consists of the following: September 30, 2024 December 31, 2023 Third Eye Capital term notes $ 7,182 $ 7,159 Third Eye Capital revolving credit facility 29,921 20,922 Third Eye Capital revolving notes Series B 64,719 54,412 Third Eye Capital revenue participation term notes 12,066 12,011 Third Eye Capital acquisition term notes 26,737 26,655 Third Eye Capital Fuels Revolving Line 39,284 32,511 Third Eye Capital Carbon Revolving Line 25,382 23,486 Construction and term loans 46,585 41,024 Cilion shareholder purchase obligation 7,188 7,028 Subordinated notes 18,771 17,625 EB-5 promissory notes 38,925 42,211 EB-5 broker promissory note 2,775 - Working capital loans 2,647 3,827 Term loans on capital expenditures 24 5,850 Total debt 322,206 294,721 Less current portion of debt 77,215 37,028 Total long term debt $ 244,991 $ 257,693 Third Eye Capital Keyes Notes On July 6, 2012, May 16, 2023, A. Term Notes. As of September 30, 2024 , the Company had $7.2 million in principal and interest outstanding under the Term Notes and $55.8 thousand unamortized debt issuance costs. The Term Notes accrue interest at 14% per annum. The Term Notes mature on April 1, 2025. B. Revolving Credit Facility . The Revolving Credit Facility accrues interest at the prime rate plus 13.75% (21.75% as of September 30, 2024 ) payable monthly in arrears. The Revolving Credit Facility matures on April 1, 2025. September 30, 2024 , AAFK had $30.5 million in principal and interest and waiver fees outstanding and $0.6 million unamortized debt issuance costs under the Revolving Credit Facility. C. Revolving Notes Series B . The Revolving Notes Series B accrues interest at the prime rate plus 13.75% (21.75% as of September 30, 2024 ) payable monthly in arrears. The Revolving Notes Series B matures on April 1, 2025. September 30, 2024 , AAFK had $65.2 million in principal and interest and waiver fees outstanding and $0.5 million unamortized debt issuance costs under the Revolving Notes Series B. D. Revenue Participation Term Notes . The Revenue Participation Term Notes bear interest at 5% per annum and mature on April 1, 2025. September 30, 2024 , AAFK had $12.2 million in principal and interest outstanding under the Revenue Participation Term Notes and $86.1 thousand unamortized debt issuance costs. E. Acquisition Term Notes . The Acquisition Term Notes accrue interest at the prime rate plus 10.75% (18.75% per annum as of September 30, 2024 ) and mature on April 1, 2025. September 30, 2024 , Aemetis Facility Keyes, Inc. had $26.9 million in principal and interest and redemption fees outstanding under the Acquisition Term Notes and $187.1 thousand unamortized debt issuance costs. not On July 31, 2024, 29 29" one April 1, 2025, April 1, 2026, The Third Eye Capital Keyes Notes contain various covenants, including but not not twelve first Third Eye Capital Reserve Facility. March 6, 2020, March 25, 2024, April 1, 2025. may may As of September 30, 2024 , we have no Third Eye Capital Revolving Credit Facility for Fuels and Carbon Lines. March 2, 2022, two March 1, 2025, ten March 1, 2026 eight poses and loans made under the Carbon Revolving Line are available for projects that reduce, capture, use, or sequester carbon with the objective of reducing carbon dioxide emissions. As of September 30, 2024 , GAFI had principal and interest outstanding of $40.2 million classified as current debt net of $0.9 million unamortized debt issuance costs. As of September 30, 2024 , ACCI had principal and interest outstanding of $1.6 million classified as current debt, $24.9 million classified as long-term debt, and $1.1 million in unamortized debt issuance costs. Cilion Shareholder Purchase Obligation . In connection with the Company’s merger with Cilion, Inc. (“Cilion”), on July 6, 2012, $5.0 million payment obligation o Cilion shareholders as merger compensation subordinated to the senior secured Third Eye Capital Notes. The liability bears interest at 3% per annum and is due and payable after the Third Eye Capital Notes have been paid in full. As of September 30, 2024 , Aemetis Facility Keyes, Inc. had $7.2 million in Subordinated Notes January 6 January 9, 2012, two six December 31, 2024. six two may September 30, 2024 December 31, 2023 million and $17.6 million in principal and interes EB- 5 5 March 4, 2011 ( January 19, 2012 July 24, 2012) 5 72 5 2 3%. 5 Advanced BioEnergy, LP received equity investments from foreign investors, and then Advanced BioEnergy used the invested equity to make loans to the Keyes Plant. The EB- 5 February 27, 2019, 5 5 six In July 2024, 5 September 30, 2024 , and December 31, 2023 , $34.5 million and $37.9 million was outstanding, respectively, on the EB- 5 On October 16, 2016, 5 5 5 5 5 March 2024, 5 5 first 5 As of both September 30, 2024 , and December 31, 2023 , $4.4 million was outstanding on the notes under the EB- 5 EB- 5 July 2024 fourth 2026 As of September 30, 2024 , $1.3 million was outstanding as current portion of long-term debt, and $1.5 million in other long-term debt. India Biodiesel Secured and Unsecured Loans. November 13, 2023, not November 6, 2023, not one September 30, 2024 December 31, 2023 Aemetis Biogas 1 October 4, 2022, "AB1 AB1 1 December 22, 2023, AB1 "AB1 AB1 1 five five January 22, 2024, ( January 22, 2025, December 22, 2042, AB1 2025, AB1 September 30, 2024 December 31, 2023 AB1 Aemetis Biogas 2 July 28, 2023, "AB2 AB2 not 2 five five AB2 August 15, 2023, ( August 15, 2025, July 28, 2043, AB2 2025, AB2 September 30, 2024 December 31, 2023 AB2 Financing Agreement for Capital Expenditures. 2018, TM no June 2024, 2018 nine September 30, 2024 Maturity Date Schedule Scheduled debt repayments for the Company’s loan obligations by year are as follows: Twelve Months ended September 30, Debt Repayments 2025 $ 77,215 2026 183,492 2027 17,469 2028 4,238 2029 1,421 Thereafter 41,605 Total debt 325,440 Debt issuance costs (3,234 ) Total debt, net of debt issuance costs $ 322,206

Note 8 - Leases

Note 8 - Leases	9 Months Ended
Note 8 - Leases	Sep. 30, 2024
Notes to Financial Statements
Operating and Finance Leases [Text Block]	8. The Company is a party to operating leases for the Company's corporate office in Cupertino, modular offices at the Keyes Plant and Biogas operations center, and laboratory facilities. We have also entered into several finance leases for mobile equipment and for the Riverbank Industrial Complex. These finance leases have a purchase option at the end of the term that we are reasonably certain we will exercise, so the leases are classified as finance leases. Our leases have remaining terms of one 12 The Company evaluates leases in accordance with ASC 842 Lease Accounting The components of lease expense are as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating lease cost Operating lease expense $ 195 $ 180 $ 571 $ 542 Short term lease expense 32 89 95 131 Variable lease expense 23 26 90 70 Total operating lease cost $ 250 $ 295 $ 756 $ 743 Finance lease cost Amortization of right-of-use assets $ 30 $ 30 $ 90 $ 91 Interest on lease liabilities 87 83 256 256 Total finance lease cost $ 117 $ 113 $ 346 $ 347 Cash paid for amounts included in the measurement of lease liabilities: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating cash flows used in operating leases $ 189 $ 169 $ 603 $ 499 Operating cash flows used in finance leases 87 83 256 256 Financing cash flows used in finance leases $ 9 $ 83 $ 170 $ 394 Supplemental non-cash flow information related to ROU asset and lease liabilities was as follows for the three nine September 30, 2024 2023 Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating leases Accretion of the lease liability $ 82 $ 81 $ 245 $ 252 Amortization of right-of-use assets 112 100 325 291 The weighted average remaining lease term and weighted average discount rate as of September 30, 2024 are as follows: Weighted Average Remaining Lease Term Operating leases (in years) 8.2 4.5 Finance leases (in years) 12.4 13.3 Weighted Average Discount Rate Operating leases 13.7 % 14.1 % Finance leases 13.3 % 13.2 % Supplemental balance sheet information related to leases is as follows: September 30, 2024 December 31, 2023 Operating leases Operating lease right-of-use assets $ 2,333 $ 2,056 Other current liability 494 406 Other long term liabilities 1,939 1,783 Total operating lease liabilities 2,433 2,189 Finance leases Property and equipment, at cost $ 2,889 $ 2,889 Accumulated depreciation (318 ) (228 ) Property and equipment, net 2,571 2,661 Other current liability 245 30 Other long term liabilities 2,557 2,687 Total finance lease liabilities 2,802 2,717 Maturities of operating lease liabilities are as follows: Twelve months ended September 30, Operating leases Finance leases 2025 $ 783 $ 176 2026 710 145 2027 703 145 2028 498 145 2029 63 145 Thereafter 1,219 9,960 Total lease payments 3,976 10,716 Less imputed interest (1,543 ) (7,914 ) Total lease liability $ 2,433 $ 2,802 The Company acts as sublessor in certain leasing arrangements, primarily related to land and buildings. Fixed sublease payments received are recognized on a straight-line basis over the sublease term. Sublease income and head lease expense for these transactions are recognized on net basis on the consolidated financial statements. Sublease income is recorded in the General and Administrative Expense section of the Consolidated Statements of Operations and Comprehensive Loss. The components of lease income are as follows for the three nine September 30, 2024 2023 Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Lease income $ 569 $ 230 $ 1,576 $ 1,182 Future lease commitments to be received by the Company as of September 30, 2024 Twelve months ended September 30, 2025 $ 1,385 2026 1,473 2027 1,419 2028 1,271 2029 1,309 Thereafter 431 Total future lease commitments $ 7,288

Note 9 - Aemetis Biogas LLC - S

Note 9 - Aemetis Biogas LLC - Series A Preferred Financing	9 Months Ended
Note 9 - Aemetis Biogas LLC - Series A Preferred Financing	Sep. 30, 2024
Notes to Financial Statements
Variable Interest Entity Disclosure [Text Block]	9. Series A Preferred Financing On December 20, 2018, X 2022, On November 6, 2024, August 31, 2024, January 31, 2025, not X February 1, 2025, January 31, 2026, 10 10.1. 470. The Company recorded Series A Preferred Unit liabilities of $123.9 million and $113.2 million as long term liabilities as of September 30, 2024 , and December 31, 2023 , respectively.

Note 10 - Stock-based Compensat

Note 10 - Stock-based Compensation	9 Months Ended
Note 10 - Stock-based Compensation	Sep. 30, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	10. 2019 On August 26, 2021, 2019 “2019 not three September 30, 2024 2019 nine September 30, 2024 Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2023 456 5,526 $ 4.42 Authorized 1,740 Options Granted (1,761 ) 1,761 $ 3.10 RSAs Granted (364 ) - $ - Exercised - (15 ) $ 2.56 Forfeited/expired 75 (75 ) $ 7.25 Balance as of September 30, 2024 146 7,197 $ 4.07 The number of outstanding option shares as of September 30, 2024 vested. Inducement Equity Plan In March 2016, not September 30, 2024 no Stock-based Compensation Expense Stock-based compensation is accounted for in accordance with ASC 718, 14, Share-Based Payment not zero The weighted average fair value calculations for the options granted during the nine September 30, 2024 2023 For the nine months ended September 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 3.93 % 3.86 % Expected volatility 115.42 % 124.62 % Expected life (years) 5.81 7.00 Market value per share on grant date $ 3.10 $ 3.60 Fair value per option on grant date $ 2.65 $ 3.29 During the nine September 30, 2024 2023 As of September 30, 2024 ha September 30, 2024

Note 11 - Warrants

Note 11 - Warrants	9 Months Ended
Note 11 - Warrants	Sep. 30, 2024
Notes to Financial Statements
Outstanding Warrants [Text Block]	11. On July 1, 2024, two December 31, 2024. two nine September 30, 2024 Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2023 530 $ 11.70 5.77 Granted 226 $ 0.01 Exercised (226 ) $ 0.01 Outstanding September 30, 2024 530 $ 11.70 5.03 All of the above outstanding warrants are fully vested and exercisable as of September 30, 2024 The fair value calculations for issued warrants are based on the following weighted average factors: For the nine months ended September 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 4.50 % 3.80 % Expected volatility 99.85 % 117.60 % Expected life (years) 2.00 4.63 Exercise price per share $ 0.01 $ 1.18 Market value per share on grant date $ 4.05 $ 4.11 Fair value per share on grant date $ 4.04 $ 3.97

Note 12 - Agreements

Note 12 - Agreements	9 Months Ended
Note 12 - Agreements	Sep. 30, 2024
Notes to Financial Statements
Collaborative Arrangement Disclosure [Text Block]	12. J.D. Heiskell Working Capital Agreements May 2023, The sales and purchases activity associated with the J.D. Heiskell Purchase Agreement and J.D. Heiskell Procurement Agreement during the three nine September 30, 2024 2023 For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Ethanol sales $ 32,812 $ 36,375 $ 87,635 $ 45,388 Wet distiller's grains sales 8,961 9,427 27,476 11,980 Corn oil sales 1,746 1,487 4,199 1,613 CDS sales 24 9 49 62 Corn purchases 33,170 37,030 97,489 48,029 September 30, 2024 December 31, 2023 Accounts receivable 19 1,073 Accounts payable 124 1,207 Ethanol and Wet Distillers Grains Marketing Arrangement. May 30, 2023, No. 1 March 31, 2025. December 31, 2024, one The agreements with J.D. Heiskell, Murex, and A.L. Gilbert include marketing and transportation services. For the three September 30, 2024 2023 , the Company expensed marketing costs of $0.7 million and $0.8 million, respectively, and for the nine September 30, 2024 2023 three September 30, 2024 2023 nine September 30, 2024 2023 Supply Trade Agreement. July 1, 2022, ten June 2025, one September 30, 2024 December 31, 2023 Forward Sale Commitments. September 30, 2024 Natural Gas Purchase Agreement. September 30, 2024 394 July October 2024, normal purchases and normal sales scope exception under ASC 815,

Note 13 - Segment Information

Note 13 - Segment Information	9 Months Ended
Note 13 - Segment Information	Sep. 30, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	13. Segment Information Aemetis recognizes three ● The “California Ethanol” segment includes the Company’s 65 million gallon per year ethanol plant in Keyes, California, and the adjacent land leased to produce CO₂. ● The “California Dairy Renewable Natural Gas” segment includes the production and sale of Renewable Natural Gas ("RNG") and associated environmental attributes, consisting of nine ten 36 ● The “India Biodiesel” segment includes the Company’s 60 million gallon per year biodiesel manufacturing plant in Kakinada, India, and administrative offices in Hyderabad, India. The Company has additional operating segments that have been determined not Summarized financial information by reportable segment for the three September 30, 2024 2023 For the three months ended September 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues $ 44,934 $ 4,250 $ 32,257 $ - $ 81,441 Gross profit 85 1,897 1,896 - 3,878 Interest expense including amortization of debt fees 7,911 808 30 2,998 11,747 Accretion and other expenses of Series A preferred units - 3,267 - - 3,267 Income tax expense - - 274 - 274 Capital expenditures 154 3,762 257 317 4,490 Depreciation 1,111 866 241 56 2,274 For the three months ended September 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues 47,439 $ 1,107 $ 20,144 $ - $ 68,690 Gross profit (loss) (1,473 ) (807 ) 2,772 - 492 Interest expense including amortization of debt fees 6,729 620 19 2,814 10,182 Accretion and other expenses of Series A preferred units - 7,739 - - 7,739 Income tax expense (benefit) - (55,164 ) (145 ) 1 (55,308 ) Capital expenditures 1,363 6,819 372 233 8,787 Depreciation 960 598 158 31 1,747 The following table summarizes financial information by reportable segment for the nine September 30, 2024 2023 For the nine months ended September 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 121,155 $ 9,640 $ 89,841 $ - $ 220,636 Gross profit (loss) (9,494 ) 3,971 6,983 - 1,460 Interest expense including amortization of debt fees 22,807 2,174 659 8,344 33,984 Accretion and other expenses of Series A preferred units - 10,055 - - 10,055 Income tax expense - 36 1,501 - 1,537 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 584 10,911 575 1,400 13,470 Depreciation 3,120 2,206 629 166 6,121 For the nine months ended September 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 59,246 $ 1,523 $ 55,184 $ - $ 115,953 Gross profit (loss) (3,807 ) (2,644 ) 7,604 - 1,153 Interest expense including amortization of debt fees 18,499 1,841 313 8,205 28,858 Accretion and other expenses of Series A preferred units - 20,188 - - 20,188 Income tax expense (benefit) - (55,151 ) 653 8 (54,490 ) Capital expenditures 2,423 14,622 523 1,027 18,595 Depreciation 3,029 1,578 470 131 5,208 California Ethanol: Sales of ethanol, WDG, one of the Company’s California Ethanol segment revenues for the three September 30, 2024 2023 Sales of ethanol, WDG, one customer (J.D. Heiskell) accounted for 98.6% and of the Company’s California Ethanol segment revenues for the nine September 30, 2024 , 2023 respectively. California Dairy Renewable Natural Gas: three nine September 30, 2024 D3 two three nine September 30, 2023 one D3 India Biodiesel: three September 30, 2024 three September 30, 2023 nine September 30, 2024 nine September 30, 2023 Total assets by reportable segment as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 California Ethanol $ 57,060 $ 67,991 California Dairy Renewable Natural Gas 110,975 92,794 India Biodiesel 40,116 34,769 All Other 39,274 47,852 Total consolidated assets $ 247,425 $ 243,406

Note 14 - Related Party Transac

Note 14 - Related Party Transactions	9 Months Ended
Note 14 - Related Party Transactions	Sep. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	14. Related Party Transactions The Company owes Eric McAfee, the Company’s Chairman and CEO, and McAfee Capital LLC (“McAfee Capital”), owned by Eric McAfee, $1 million in connection with employment agreements, bonus awards, expense reimbursements, and guarantee fees in connection with McAfee Capital’s guarantees of the Company’s indebtedness with Third Eye Capital. The Company owes various members of the Board amounts totaling $0.3 million as of September 30, 2024 , and December 31, 2023 , in connection with board compensation fees, which are included in accounts payable on the balance sheet. For the three September 30, 2024 2023 , the Company expensed $0.1 million respectively, in connection with board compensation fees. For the nine September 30, 2024 2023 , the Company expensed $0.3 million respectively, in connection with board compensation fees.

Note 15 - Subsequent Events

Note 15 - Subsequent Events	9 Months Ended
Note 15 - Subsequent Events	Sep. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	15. Subsequent Events Series A Preferred Unit Purchase Agreement On November 6, 2024, X August 31, 2024, January 31, 2025, not X February 1, 2025, January 31, 2026, prime rate 10 10.1,

Note 16 - Liquidity

Note 16 - Liquidity	9 Months Ended
Note 16 - Liquidity	Sep. 30, 2024
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	16. The accompanying financial statements have been prepared contemplating the realization of assets and satisfaction of liabilities in the normal course of business. As a result of negative capital, negative operating results, and collateralization of substantially all of the Company assets, the Company has been reliant on its senior secured lender to provide extensions to the maturity dates of its debt and loan facilities and was required in 2023 twelve twelve Operations and Project Development For the Keyes Plant, we plan to operate the plant and continue to improve its financial performance by adopting new technologies or process changes that allow for energy efficiency, cost reduction, or revenue enhancements, as well as execute upon awarded grants that support investments in equipment to improve energy and operational efficiencies resulting in lower cost, lower carbon emissions, and overall margin improvement. For Aemetis Biogas, we plan to operate our existing biogas digesters to produce and sell Renewable Natural Gas (RNG) and the associated Federal D3 2023 2024, For the Kakinada Plant, we plan to continue to sell our biodiesel to India Oil Marketing Companies ("OMCs") pursuant to cost-plus contracts. We are also continuing to upgrade the plant to increase feedstock flexibility (and thereby lower feedstock costs), increase production capacity, and produce new products. Additionally, we are in the process of negotiating contractual arrangements for the export of refined animal tallow into international markets. Financing We plan to continue to locate funding for existing and new business opportunities through a combination of working with our senior lender, restructuring existing loan agreements, entering into additional debt agreements for specific projects, obtaining project specific equity and debt for development projects, and obtaining additional debt from the current EB- 5

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Sep. 30, 2024	Sep. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		5. Other Current Reports Item 1.01 On November 6, 2024, 10.1 9. 15. Item 5.02 Todd A. Waltz, Executive Vice President and Chief Financial Officer of Aemetis, Inc., has informed the Company of his desire to retire from the position of Executive Vice President and Chief Financial Officer, provided that Mr. Waltz has indicated that he will remain in his current position until the Company has identified a successor, he will assist with transition to a new Chief Financial Officer, and he will remain with the Company in an employee or consulting capacity following the transition to provide continuity of operations. Mr. Waltz has also indicated that he does not six twelve not
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Consolidation These consolidated financial statements include the accounts of Aemetis, Inc. and its subsidiaries. We consolidate all entities in which we have a controlling financial interest. A controlling financial interest is usually obtained through ownership of a majority of the voting interests. However, an enterprise must consolidate a variable interest entity (“VIE”) if the enterprise is the primary beneficiary of the VIE, even if the enterprise does not All intercompany balances and transactions have been eliminated in consolidation. The accompanying consolidated condensed balance sheet as of September 30, 2024 three nine September 30, 2024 2023 nine September 30, 2024 2023 three nine September 30, 2024 2023 December 31, 2023 2023 The consolidated condensed financial statements in this report should be read in conjunction with the 2023 10 December 31, 2023 In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three nine September 30, 2024 2023 December 31, 2023 three nine September 30, 2024 not There have been no 1 10 December 31, 2023.

Note 2 - Revenue (Tables)

Note 2 - Revenue (Tables)	9 Months Ended
Note 2 - Revenue (Tables)	Sep. 30, 2024
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Ethanol sales $ 33,925 $ 36,375 $ 88,748 $ 45,388 Wet distiller's grains sales 8,961 9,427 27,476 11,980 Other sales 2,048 1,637 4,931 1,878 Total $ 44,934 $ 47,439 $ 121,155 $ 59,246 For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 RNG, LCFS and D3 RIN sales $ 4,250 $ 1,107 $ 9,640 $ 1,523
Schedule of America by Product Category [Table Text Block]	For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Biodiesel sales $ 31,121 $ 19,291 $ 85,821 $ 53,292 Other sales 1,136 853 4,020 1,892 Total $ 32,257 $ 20,144 $ 89,841 $ 55,184

Note 3 - Cash and Cash Equiva_2

Note 3 - Cash and Cash Equivalents (Tables)	9 Months Ended
Note 3 - Cash and Cash Equivalents (Tables)	Sep. 30, 2024
Notes Tables
Schedule of Cash and Cash Equivalents [Table Text Block]	As of September 30, 2024 December 31, 2023 Cash and cash equivalents $ 296 $ 2,667 Restricted cash included in other current assets 115 289 Restricted cash included in other assets 2,882 3,324 Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 3,293 $ 6,280

Note 4 - Basic and Diluted Ne_2

Note 4 - Basic and Diluted Net Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	As of September 30, 2024 September 30, 2023 Common stock options and warrants 7,728 3,281 Debt with conversion feature at $ 30 1,151 1,259 Total number of potentially dilutive shares 8,879 4,540

Note 5 - Inventories (Tables)

Note 5 - Inventories (Tables)	9 Months Ended
Note 5 - Inventories (Tables)	Sep. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	As of September 30, 2024 December 31, 2023 Raw materials $ 10,642 $ 9,907 Work-in-progress 1,591 1,682 Finished goods 7,559 6,702 Total inventories $ 19,792 $ 18,291

Note 6 - Property, Plant and _2

Note 6 - Property, Plant and Equipment (Tables)	9 Months Ended
Note 6 - Property, Plant and Equipment (Tables)	Sep. 30, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of September 30, 2024 December 31, 2023 Land $ 7,341 $ 7,345 Plant and buildings 171,814 136,318 Furniture and fixtures 2,641 2,266 Machinery and equipment 5,695 14,982 Construction in progress 52,978 73,057 Property held for development 15,431 15,431 Finance lease right of use assets 2,889 2,889 Total gross property, plant & equipment 258,789 252,288 Less accumulated depreciation (62,850 ) (57,180 ) Total net property, plant & equipment $ 195,939 $ 195,108
Depreciation Of Property, Plant, and Equipment [Table Text Block]	Years Plant and buildings 20 - 30 Machinery and equipment 5 - 15 Furniture and fixtures 3 - 5

Note 7 - Debt (Tables)

Note 7 - Debt (Tables)	9 Months Ended
Note 7 - Debt (Tables)	Sep. 30, 2024
Notes Tables
Schedule of Debt [Table Text Block]	September 30, 2024 December 31, 2023 Third Eye Capital term notes $ 7,182 $ 7,159 Third Eye Capital revolving credit facility 29,921 20,922 Third Eye Capital revolving notes Series B 64,719 54,412 Third Eye Capital revenue participation term notes 12,066 12,011 Third Eye Capital acquisition term notes 26,737 26,655 Third Eye Capital Fuels Revolving Line 39,284 32,511 Third Eye Capital Carbon Revolving Line 25,382 23,486 Construction and term loans 46,585 41,024 Cilion shareholder purchase obligation 7,188 7,028 Subordinated notes 18,771 17,625 EB-5 promissory notes 38,925 42,211 EB-5 broker promissory note 2,775 - Working capital loans 2,647 3,827 Term loans on capital expenditures 24 5,850 Total debt 322,206 294,721 Less current portion of debt 77,215 37,028 Total long term debt $ 244,991 $ 257,693
Schedule of Maturities of Long-Term Debt [Table Text Block]	Twelve Months ended September 30, Debt Repayments 2025 $ 77,215 2026 183,492 2027 17,469 2028 4,238 2029 1,421 Thereafter 41,605 Total debt 325,440 Debt issuance costs (3,234 ) Total debt, net of debt issuance costs $ 322,206

Note 8 - Leases (Tables)

Note 8 - Leases (Tables)	9 Months Ended
Note 8 - Leases (Tables)	Sep. 30, 2024
Notes Tables
Lease, Cost [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating lease cost Operating lease expense $ 195 $ 180 $ 571 $ 542 Short term lease expense 32 89 95 131 Variable lease expense 23 26 90 70 Total operating lease cost $ 250 $ 295 $ 756 $ 743 Finance lease cost Amortization of right-of-use assets $ 30 $ 30 $ 90 $ 91 Interest on lease liabilities 87 83 256 256 Total finance lease cost $ 117 $ 113 $ 346 $ 347 Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating cash flows used in operating leases $ 189 $ 169 $ 603 $ 499 Operating cash flows used in finance leases 87 83 256 256 Financing cash flows used in finance leases $ 9 $ 83 $ 170 $ 394
Supplemental Non-cash Flow Information Related to Leases [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Operating leases Accretion of the lease liability $ 82 $ 81 $ 245 $ 252 Amortization of right-of-use assets 112 100 325 291 The weighted average remaining lease term and weighted average discount rate as of September 30, 2024 are as follows: Weighted Average Remaining Lease Term Operating leases (in years) 8.2 4.5 Finance leases (in years) 12.4 13.3 Weighted Average Discount Rate Operating leases 13.7 % 14.1 % Finance leases 13.3 % 13.2 %
Supplemental Balance Sheet Information Related to Leases [Table Text Block]	September 30, 2024 December 31, 2023 Operating leases Operating lease right-of-use assets $ 2,333 $ 2,056 Other current liability 494 406 Other long term liabilities 1,939 1,783 Total operating lease liabilities 2,433 2,189 Finance leases Property and equipment, at cost $ 2,889 $ 2,889 Accumulated depreciation (318 ) (228 ) Property and equipment, net 2,571 2,661 Other current liability 245 30 Other long term liabilities 2,557 2,687 Total finance lease liabilities 2,802 2,717
Lease Term [Table Text Block]	Twelve months ended September 30, Operating leases Finance leases 2025 $ 783 $ 176 2026 710 145 2027 703 145 2028 498 145 2029 63 145 Thereafter 1,219 9,960 Total lease payments 3,976 10,716 Less imputed interest (1,543 ) (7,914 ) Total lease liability $ 2,433 $ 2,802
Operating Lease, Lease Income [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Lease income $ 569 $ 230 $ 1,576 $ 1,182
Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]	Twelve months ended September 30, 2025 $ 1,385 2026 1,473 2027 1,419 2028 1,271 2029 1,309 Thereafter 431 Total future lease commitments $ 7,288

Note 10 - Stock-based Compens_2

Note 10 - Stock-based Compensation (Tables)	9 Months Ended
Note 10 - Stock-based Compensation (Tables)	Sep. 30, 2024
Notes Tables
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Shares Available for Grant Number of Shares Outstanding Weighted-Average Exercise Price Balance as of December 31, 2023 456 5,526 $ 4.42 Authorized 1,740 Options Granted (1,761 ) 1,761 $ 3.10 RSAs Granted (364 ) - $ - Exercised - (15 ) $ 2.56 Forfeited/expired 75 (75 ) $ 7.25 Balance as of September 30, 2024 146 7,197 $ 4.07
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the nine months ended September 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 3.93 % 3.86 % Expected volatility 115.42 % 124.62 % Expected life (years) 5.81 7.00 Market value per share on grant date $ 3.10 $ 3.60 Fair value per option on grant date $ 2.65 $ 3.29

Note 11 - Warrants (Tables)

Note 11 - Warrants (Tables)	9 Months Ended
Note 11 - Warrants (Tables)	Sep. 30, 2024
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Warrants Outstanding & Exercisable Weighted - Average Exercise Price Average Remaining Term in Years Outstanding December 31, 2023 530 $ 11.70 5.77 Granted 226 $ 0.01 Exercised (226 ) $ 0.01 Outstanding September 30, 2024 530 $ 11.70 5.03
Schedule of Warrants, Valuation Assumptions [Table Text Block]	For the nine months ended September 30, Description 2024 2023 Dividend-yield - % - % Risk-free interest rate 4.50 % 3.80 % Expected volatility 99.85 % 117.60 % Expected life (years) 2.00 4.63 Exercise price per share $ 0.01 $ 1.18 Market value per share on grant date $ 4.05 $ 4.11 Fair value per share on grant date $ 4.04 $ 3.97

Note 12 - Agreements (Tables)

Note 12 - Agreements (Tables)	9 Months Ended
Note 12 - Agreements (Tables)	Sep. 30, 2024
Notes Tables
Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]	For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Ethanol sales $ 32,812 $ 36,375 $ 87,635 $ 45,388 Wet distiller's grains sales 8,961 9,427 27,476 11,980 Corn oil sales 1,746 1,487 4,199 1,613 CDS sales 24 9 49 62 Corn purchases 33,170 37,030 97,489 48,029 September 30, 2024 December 31, 2023 Accounts receivable 19 1,073 Accounts payable 124 1,207

Note 13 - Segment Information (

Note 13 - Segment Information (Tables)	9 Months Ended
Note 13 - Segment Information (Tables)	Sep. 30, 2024
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	For the three months ended September 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues $ 44,934 $ 4,250 $ 32,257 $ - $ 81,441 Gross profit 85 1,897 1,896 - 3,878 Interest expense including amortization of debt fees 7,911 808 30 2,998 11,747 Accretion and other expenses of Series A preferred units - 3,267 - - 3,267 Income tax expense - - 274 - 274 Capital expenditures 154 3,762 257 317 4,490 Depreciation 1,111 866 241 56 2,274 For the three months ended September 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All Other Total Revenues 47,439 $ 1,107 $ 20,144 $ - $ 68,690 Gross profit (loss) (1,473 ) (807 ) 2,772 - 492 Interest expense including amortization of debt fees 6,729 620 19 2,814 10,182 Accretion and other expenses of Series A preferred units - 7,739 - - 7,739 Income tax expense (benefit) - (55,164 ) (145 ) 1 (55,308 ) Capital expenditures 1,363 6,819 372 233 8,787 Depreciation 960 598 158 31 1,747 For the nine months ended September 30, 2024 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 121,155 $ 9,640 $ 89,841 $ - $ 220,636 Gross profit (loss) (9,494 ) 3,971 6,983 - 1,460 Interest expense including amortization of debt fees 22,807 2,174 659 8,344 33,984 Accretion and other expenses of Series A preferred units - 10,055 - - 10,055 Income tax expense - 36 1,501 - 1,537 Loss on asset disposals 3,644 - - - 3,644 Capital expenditures 584 10,911 575 1,400 13,470 Depreciation 3,120 2,206 629 166 6,121 For the nine months ended September 30, 2023 California Ethanol California Dairy Renewable Natural Gas India Biodiesel All other Total Revenues $ 59,246 $ 1,523 $ 55,184 $ - $ 115,953 Gross profit (loss) (3,807 ) (2,644 ) 7,604 - 1,153 Interest expense including amortization of debt fees 18,499 1,841 313 8,205 28,858 Accretion and other expenses of Series A preferred units - 20,188 - - 20,188 Income tax expense (benefit) - (55,151 ) 653 8 (54,490 ) Capital expenditures 2,423 14,622 523 1,027 18,595 Depreciation 3,029 1,578 470 131 5,208
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	September 30, 2024 December 31, 2023 California Ethanol $ 57,060 $ 67,991 California Dairy Renewable Natural Gas 110,975 92,794 India Biodiesel 40,116 34,769 All Other 39,274 47,852 Total consolidated assets $ 247,425 $ 243,406

Note 2 - Revenue - Disaggregati

Note 2 - Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
California Ethanol [Member] \| Ethanol Sales [Member]
Ethanol sales	$ 33,925	$ 36,375	$ 88,748	$ 45,388
California Ethanol [Member] \| Wet Distillers Grains [Member]
Ethanol sales	8,961	9,427	27,476	11,980
California Ethanol [Member] \| Product and Service, Other [Member]
Ethanol sales	2,048	1,637	4,931	1,878
California Dairy Renewable Natural Gas [Member] \| Gas Molecules and RIN Credits [Member]
Ethanol sales	4,250	1,107	9,640	1,523
RNG, LCFS and D3 RIN Sales [Member]
Ethanol sales	$ 44,934	$ 47,439	$ 121,155	$ 59,246

Note 2 - Revenue - Schedule Of

Note 2 - Revenue - Schedule Of America By Product Category (Details) - India Biodiesel [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Ethanol sales	$ 32,257	$ 20,144	$ 89,841	$ 55,184
Renewable Energy, Biodiesel [Member]
Ethanol sales	31,121	19,291	85,821	53,292
Product and Service, Other [Member]
Ethanol sales	$ 1,136	$ 853	$ 4,020	$ 1,892

Note 3 - Cash and Cash Equiva_3

Note 3 - Cash and Cash Equivalents - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Cash and cash equivalents	$ 296	$ 2,667
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	3,293	6,280
Other Current Assets [Member]
Restricted cash	115	289
Other Assets [Member]
Restricted cash	$ 2,882	$ 3,324

Note 4 - Basic and Diluted Ne_3

Note 4 - Basic and Diluted Net Income (Loss) Per Share - Schedule of Dilutive Securities (Details) - $ / shares shares in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	8,879	4,540
Debt with Conversion Feature [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 30	$ 30
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	1,151	1,259
Common Stock Options and Warrants [Member]
Total Number of Potentially Dilutive Shares Excluded from the basic and diluted net loss per share calculation (in shares)	7,728	3,281

Note 4 - Basic and Diluted Ne_4

Note 4 - Basic and Diluted Net Income (Loss) Per Share - Schedule of Dilutive Securities (Details) (Parentheticals) - $ / shares	Sep. 30, 2024	Sep. 30, 2023
Debt with Conversion Feature [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 30	$ 30

Note 5 - Inventories (Details T

Note 5 - Inventories (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Inventory Write-down	$ 2	$ 58

Note 5 - Inventories - Schedule

Note 5 - Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Raw materials	$ 10,642	$ 9,907
Work-in-progress	1,591	1,682
Finished goods	7,559	6,702
Total inventories	$ 19,792	$ 18,291

Note 6 - Property, Plant and _3

Note 6 - Property, Plant and Equipment (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Capitalized Interest Costs, Including Allowance for Funds Used During Construction	$ 1,000	$ 1,500	$ 4,000	$ 3,900
Depreciation	$ 2,274	$ 1,747	$ 6,121	$ 5,208

Note 6 - Property, Plant and _4

Note 6 - Property, Plant and Equipment - Schedule of Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Land	$ 7,341	$ 7,345
Plant and buildings	171,814	136,318
Furniture and fixtures	2,641	2,266
Machinery and equipment	5,695	14,982
Construction in progress	52,978	73,057
Property held for development	15,431	15,431
Finance lease right of use assets	2,889	2,889
Total gross property, plant & equipment	258,789	252,288
Less accumulated depreciation	(62,850)	(57,180)
Total net property, plant & equipment	$ 195,939	$ 195,108

Note 6 - Property, Plant and _5

Note 6 - Property, Plant and Equipment - Depreciation of Property, Plant, and Equipment (Details)	Sep. 30, 2024
Minimum [Member] \| Building [Member]
Useful life (Year)	20 years
Minimum [Member] \| Machinery and Equipment [Member]
Useful life (Year)	5 years
Minimum [Member] \| Furniture and Fixtures [Member]
Useful life (Year)	3 years
Maximum [Member] \| Building [Member]
Useful life (Year)	30 years
Maximum [Member] \| Machinery and Equipment [Member]
Useful life (Year)	15 years
Maximum [Member] \| Furniture and Fixtures [Member]
Useful life (Year)	5 years

Note 7 - Debt (Details Textual)

Note 7 - Debt (Details Textual) - USD ($)						3 Months Ended	9 Months Ended		89 Months Ended
Note 7 - Debt (Details Textual) - USD ($)	Jul. 28, 2023	May 16, 2023	Oct. 04, 2022	Mar. 02, 2022	Jul. 06, 2012	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024	Jul. 31, 2024	Jul. 01, 2024	Dec. 31, 2023	Mar. 31, 2023	Aug. 01, 2022	Jul. 26, 2022	May 01, 2020	Mar. 06, 2020	Feb. 27, 2019	Jan. 09, 2012
Long-Term Debt						$ 322,206,000	$ 322,206,000
Short-Term Debt						$ 21,418,000	$ 21,418,000					$ 23,443,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)						$ 11.7	$ 11.7					$ 11.7
Warrants and Rights Outstanding, Term (Year)						5 years 10 days	5 years 10 days
Gain (Loss) on Extinguishment of Debt							$ 162,000	$ 0
Proceeds from Issuance of Debt							12,534,000	$ 41,449,000
Debt, Long-Term and Short-Term, Combined Amount						$ 322,206,000	322,206,000					$ 294,721,000
Long-Term Debt, Current Maturities						55,797,000	55,797,000					13,585,000
Long-Term Debt, Excluding Current Maturities						244,991,000	244,991,000					257,693,000
Property, Plant and Equipment, Net						195,939,000	195,939,000					195,108,000
Accounts Payable, Current						37,254,000	37,254,000					32,132,000
Other Long-Term Debt, Noncurrent						54,583,000	54,583,000					51,717,000
AAFK [Member] \| Warrants in Connection With Subordinated Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)											$ 0.01								$ 0.01
Warrants and Rights Outstanding, Term (Year)											2 years								2 years
Capital Revolving Credit Facility Fuels And Carbon Lines [Member] \| GAFI and ACCI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 100,000,000
Fuels Revolving Line [Member] \| GAFI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				50,000,000
Carbon Revolving Line [Member] \| ACCI [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 50,000,000
Third Eye Capital [Member] \| Mr. McAfee [Member]
Net Amount at Risk by Product and Guarantee, Net Amount at Risk						10,000,000	10,000,000
Third Eye Capital [Member] \| Revolving Credit Facility [Member]
Debt Instrument, Face Amount					$ 18,000,000
Long-Term Debt						30,500,000	30,500,000
Debt Issuance Costs, Net						$ 600,000	$ 600,000
Debt Instrument, Interest Rate, Stated Percentage						21.75%	21.75%
Third Eye Capital [Member] \| Revolving Credit Facility [Member] \| Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					13.75%
Third Eye Capital [Member] \| Acquisition Term Notes [Member]
Debt Instrument, Face Amount					$ 15,000,000
Revolving Notes Series B [Member] \| Revolving Credit Facility [Member]
Long-Term Debt						$ 65,200,000	$ 65,200,000
Debt Issuance Costs, Net						$ 500,000	$ 500,000
Debt Instrument, Interest Rate, Stated Percentage						21.75%	21.75%
Revolving Notes Series B [Member] \| Revolving Credit Facility [Member] \| Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		13.75%
Term Loan [Member] \| Third Eye Capital [Member]
Debt Instrument, Face Amount					7,200,000
Long-Term Debt						$ 7,200,000	$ 7,200,000
Debt Issuance Costs, Net						55,800	55,800
Revenue Participation Term Notes [Member] \| Third Eye Capital [Member]
Debt Instrument, Face Amount					$ 10,000,000
Debt Instrument, Interest Rate, Stated Percentage									5%
Revenue Participation Term Notes [Member] \| Third Eye Capital [Member] \| AAFK [Member]
Long-Term Debt						12,200,000	12,200,000
Debt Issuance Costs, Net						$ 86,100	$ 86,100
Term Notes [Member] \| Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage						14%	14%
Extension Fee						1%
Debt Instrument, Extension Fee, Percentage Payable by Increasing Debt Outstanding						50%
Debt Instrument, Extension Fee, Percentage Payable with Cash						50%
Debt Instrument, Extension Fee, Percentage Payable with Common Stock						110%
Acquisition Term Notes [Member] \| Third Eye Capital [Member]
Long-Term Debt						$ 26,900	$ 26,900
Debt Issuance Costs, Net						$ 187,100	$ 187,100
Debt Instrument, Interest Rate, Stated Percentage						18.75%	18.75%
Acquisition Term Notes [Member] \| Third Eye Capital [Member] \| Aemetis Facility Keyes, Inc. [Member]
Debt Instrument, Redemption Fee						$ 7,500,000	$ 7,500,000
Acquisition Term Notes [Member] \| Third Eye Capital [Member] \| Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate					10.75%
Reserve Liquidity Facility [Member] \| Third Eye Capital [Member]
Debt Instrument, Face Amount																	$ 18,000,000
Long-Term Debt						0	0
Line of Credit Facility, Maximum Borrowing Capacity																	$ 85,000,000
Debt Instrument, Non-refundable Standby Fee, Percent of Difference Between Principal Amount and the Commitment																	2%
Dbet Instrument, Non Refundable One Time Fees																	$ 500,000
Reserve Liquidity Facility Paid Monthly in Arrears [Member] \| Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage																	30%
Reserve Liquidity Facility if Event of Default Occurred and Continues [Member] \| Third Eye Capital [Member]
Debt Instrument, Interest Rate, Stated Percentage																	40%
Fuels Revolving Line [Member] \| GAFI [Member]
Debt Instrument, Interest Rate, Stated Percentage				10%
Fuels Revolving Line [Member] \| Prime Rate [Member] \| GAFI [Member]
Debt Instrument, Basis Spread on Variable Rate				6%
Carbon Revolving Line [Member] \| GAFI [Member]
Debt Issuance Costs, Net						900,000	900,000
Short-Term Debt						40,200,000	40,200,000
Carbon Revolving Line [Member] \| ACCI [Member]
Long-Term Debt						24,900,000	24,900,000
Debt Issuance Costs, Net						1,100,000	1,100,000
Debt Instrument, Interest Rate, Stated Percentage				8%
Short-Term Debt						1,600,000	1,600,000
Carbon Revolving Line [Member] \| Prime Rate [Member] \| ACCI [Member]
Debt Instrument, Basis Spread on Variable Rate				4%
Cilion Shareholder Seller Notes Payable [Member]
Debt Instrument, Face Amount					$ 5,000,000
Long-Term Debt						7,200,000	7,200,000
Debt Instrument, Interest Rate, Stated Percentage					3%
Debt, Long-Term and Short-Term, Combined Amount						7,188,000	7,188,000					7,028,000
Subordinated Notes [Member] \| AAFK [Member]
Short-Term Debt						18,800,000	18,800,000					17,600,000
Debt Instrument, Fee Amount																			$ 3,400,000
Debt Instrument Fee Rate																			10%
Debt Extension Fee, Percentage																			10%
EB5 Phase I Notes [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)																		$ 30
Proceeds from Issuance of Debt									$ 4,000,000
EB5 Phase I Notes [Member] \| Maximum [Member]
Debt Instrument, Additional Investment Available to Issue									$ 200,000,000
EB5 Phase I Notes [Member] \| Minimum [Member]
Debt Instrument, Investment Raised Per Investor													$ 800,000			$ 500,000
EB-5 Promissory Notes [Member]
Long-Term Debt						34,500,000	34,500,000					37,900,000
Debt Instrument, Interest Rate, Effective Percentage										1%
Gain (Loss) on Extinguishment of Debt							162,000
Debt, Long-Term and Short-Term, Combined Amount						38,925,000	38,925,000					42,211,000
EB5 Phase II Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount						4,400,000	4,400,000					4,400,000
EB-5 Broker Promissory Note [Member]
Debt Instrument, Face Amount										$ 3,300,000
Long-Term Debt						0	0
Debt, Long-Term and Short-Term, Combined Amount						2,775,000	2,775,000					0
Long-Term Debt, Current Maturities						1,300,000	1,300,000
Long-Term Debt, Excluding Current Maturities						1,500,000	1,500,000
Secunderabad Oils [Member]
Debt Instrument, Interest Rate, Stated Percentage															18%
Short-Term Debt						2,600,000	2,600,000					3,800,000
Debt Agreement, Maximum Borrowing Capacity															$ 3,600,000
Leo Edibles & Fats Limited [Member]
Debt Agreement, Maximum Borrowing Capacity														$ 1,270,000
Construction Loan Agreement [Member]
Long-Term Debt						25,100,000	25,100,000					25,100,000
Debt Instrument, Interest Rate, Stated Percentage			9.25%
Debt, Long-Term and Short-Term, Combined Amount						46,585,000	46,585,000					41,024,000
Debt Agreement, Maximum Borrowing Capacity			$ 25,000,000
Construction Loan Agreement [Member] \| US Treasury (UST) Interest Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			5%
Construction Loan Agreement 2 [Member]
Long-Term Debt						22,300,000	22,300,000					16,800,000
Debt Issuance Costs, Net						800,000	800,000					$ 800,000
Debt Instrument, Interest Rate, Stated Percentage	8.75%
Debt Agreement, Maximum Borrowing Capacity	$ 25,000,000
Construction Loan Agreement 2 [Member] \| US Treasury (UST) Interest Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	5%
Financing Agreement For Capital Expenditures [Member]
Long-Term Debt						3,600,000	3,600,000
Short-Term Debt						2,200,000	2,200,000
Property, Plant and Equipment, Net						9,600,000	9,600,000
Accounts Payable, Current						200,000	200,000
Other Long-Term Debt, Noncurrent						$ 3,600,000	$ 3,600,000

Note 7 - Debt- Schedule of Debt

Note 7 - Debt- Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Debt, Long-Term and Short-Term, Combined Amount	$ 322,206	$ 294,721
Short-Term Debt	21,418	23,443
Less current portion of debt	77,215	37,028
Total long term debt	244,991	257,693
Third Eye Capital Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	7,182	7,159
Third Eye Capital Revolving Credit Facility [Member]
Debt, Long-Term and Short-Term, Combined Amount	29,921	20,922
Revolving Notes Series B [Member]
Debt, Long-Term and Short-Term, Combined Amount	64,719	54,412
Third Eye Capital Revenue Participation Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	12,066	12,011
Third Eye Capital Acquisition Term Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	26,737	26,655
Third Eye Capital Fuels Revolving Line [Member]
Debt, Long-Term and Short-Term, Combined Amount	39,284	32,511
Third Eye Capital Carbon Revolving Line [Member]
Debt, Long-Term and Short-Term, Combined Amount	25,382	23,486
Construction Loan Agreement [Member]
Debt, Long-Term and Short-Term, Combined Amount	46,585	41,024
Cilion Shareholder Seller Notes Payable [Member]
Debt, Long-Term and Short-Term, Combined Amount	7,188	7,028
Subordinated Notes 1 [Member]
Short-Term Debt	18,771	17,625
EB-5 Promissory Notes [Member]
Debt, Long-Term and Short-Term, Combined Amount	38,925	42,211
EB-5 Broker Promissory Note [Member]
Debt, Long-Term and Short-Term, Combined Amount	2,775	0
Total long term debt	1,500
Working capital Loan [Member]
Short-Term Debt	2,647	3,827
Term Loan On Equipment Purchase [Member]
Debt, Long-Term and Short-Term, Combined Amount	$ 24	$ 5,850

Note 7 - Debt - Maturities of L

Note 7 - Debt - Maturities of Long-term Debt (Details) $ in Thousands	Sep. 30, 2024 USD ($)
2025	$ 77,215
2026	183,492
2027	17,469
2028	4,238
2029	1,421
Thereafter	41,605
Total debt	325,440
Debt issuance costs	(3,234)
Total debt, net of debt issuance costs	$ 322,206

Note 8 - Leases (Details Textua

Note 8 - Leases (Details Textual)	6 Months Ended
Note 8 - Leases (Details Textual)	Sep. 30, 2024
Minimum [Member]
Lease Term (Year)	1 year
Maximum [Member]
Lease Term (Year)	13 years

Note 8 - Leases - Lease Cost (D

Note 8 - Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating lease expense	$ 195	$ 180	$ 571	$ 542
Short term lease expense	32	89	95	131
Variable lease expense	23	26	90	70
Total operating lease cost	250	295	756	743
Amortization of right-of-use assets	30	30	90	91
Interest on lease liabilities	87	83	256	256
Total finance lease cost	117	113	346	347
Operating cash flows used in operating leases	189	169	603	499
Operating cash flows used in finance leases	87	83	256	256
Financing cash flows used in finance leases	$ 9	$ 83	$ 170	$ 394

Note 8 - Leases - Non-cash Flow

Note 8 - Leases - Non-cash Flow Information Related to ROU Asset and Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accretion of the lease liability	$ 82	$ 81	$ 245	$ 252
Amortization of right-of-use assets	$ 112	$ 100	$ 325	$ 291
Operating leases (in years) (Year)	8 years 2 months 12 days	4 years 6 months	8 years 2 months 12 days	4 years 6 months
Finance leases (in years) (Year)	12 years 4 months 24 days	13 years 3 months 18 days	12 years 4 months 24 days	13 years 3 months 18 days
Operating leases	13.70%	14.10%	13.70%	14.10%
Finance leases	13.30%	13.20%	13.30%	13.20%

Note 8 - Leases - Supplemental

Note 8 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Operating lease right-of-use assets	$ 2,333	$ 2,056
Other current liability	494	406
Other long term liabilities	1,939	1,783
Total operating lease liabilities	2,433	2,189
Property and equipment, at cost	2,889	2,889
Accumulated depreciation	(318)	(228)
Property and equipment, net	2,571	2,661
Other current liability	245	30
Other long term liabilities	2,557	2,687
Total finance lease liabilities	$ 2,802	$ 2,717

Note 8 - Leases - Supplementa_2

Note 8 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) (Parentheticals)	Sep. 30, 2024	Dec. 31, 2023
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long term liabilities	Other long term liabilities
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long term liabilities	Other long term liabilities

Note 8 - Leases - Maturities of

Note 8 - Leases - Maturities of Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
2025, Operating leases	$ 783
2025, Finance leases	176
2026, Operating leases	710
2026, Finance leases	145
2027, Operating leases	703
2027, Finance leases	145
2028, Operating leases	498
2028, Finance leases	145
2029, Operating leases	63
2029, Finance leases	145
Thereafter, Operating leases	1,219
Thereafter, Finance leases	9,960
Total lease payments, Operating leases	3,976
Total lease payments, Finance leases	10,716
Less imputed interest, Operating leases	(1,543)
Less imputed interest, Finance leases	(7,914)
Total operating lease liability	2,433	$ 2,189
Total finance lease liability	$ 2,802	$ 2,717

Note 8 - Leases - Lease Income

Note 8 - Leases - Lease Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Lease income	$ 569	$ 230	$ 1,576	$ 1,182

Note 8 - Leases - Future Minimu

Note 8 - Leases - Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2024 USD ($)
2025	$ 1,385
2026	1,473
2027	1,419
2028	1,271
2029	1,309
Thereafter	431
Total future lease commitments	$ 7,288

Note 9 - Aemetis Biogas LLC -_2

Note 9 - Aemetis Biogas LLC - Series A Preferred Financing (Details Textual) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended	44 Months Ended
	Feb. 08, 2024	Dec. 20, 2018	Dec. 31, 2022	Aug. 08, 2022	Sep. 30, 2024	Dec. 31, 2023
Common Units [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)		5,000,000
Preferred Units Series A [Member]
Common Units Authorized (in shares)		11,000,000
Preferred Units, Authorized (in shares)		6,000,000
Preferred Units Series A [Member] \| Second Tranche [Member
Preferred Units, Issued (in shares)			6,000,000
Preferred Units Issued Value			$ 30
Stock Redeemed or Called During Period, Shares (in shares)				20,000
Preferred Units Redeemed, Value				$ 0.3
Series A Preferred Stocks [Member]
Common Units Issued (in shares)		6,000,000
Common Units Issuance Value (in dollars per share)		$ 5
PUPA Fifth Amendment [Member]
Preferred Units Issued Value	$ 115.5
Credit Agreement, Interest Rate	16%
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent					$ 123.9	$ 113.2
PUPA Fifth Amendment [Member] \| Prime Rate [Member]
Credit Agreement, Interest Rate	10%

Note 10 - Stock-based Compens_3

Note 10 - Stock-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2016
The 2019 Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)	4,900,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 5.9	$ 5.9
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 8 months 23 days
The 2019 Stock Plan [Member] \| Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		363,500	243,850
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 3.1	$ 3.6
Inducement Equity Plan Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				100,000

Note 10 - Stock-based Compens_4

Note 10 - Stock-based Compensation - Schedule of Share-based Payment Award (Details) - The 2019 Stock Plan [Member] - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Balance, Shares Available for Grant (in shares)	456,000
Balance, outstanding (in shares)	5,526,000
Balance, Weighted-Average Exercise Price (in dollars per share)	$ 4.42
Authorized, shares (in shares)	1,740,000
Options Granted, shares (in shares)	(1,761,000)
Options Granted, shares (in shares)	1,761,000
Options Granted, Weighted-Average Exercise Price (in dollars per share)	$ 3.1
Exercised, outstanding (in shares)	(15,000)
Exercised, Weighted-Average Exercise Price (in dollars per share)	$ 2.56
Forfeited/expired, shares available (in shares)	75,000
Forfeited/expired, outstanding (in shares)	(75,000)
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share)	$ 7.25
Balance, Shares Available for Grant (in shares)	146,000
Balance, outstanding (in shares)	7,197,000
Balance, Weighted-Average Exercise Price (in dollars per share)	$ 4.07
Restricted Stock [Member]
RSAs Granted, shares (in shares)	(363,500)	(243,850)

Note 10 - Stock-based Compens_5

Note 10 - Stock-based Compensation - Fair Value Assumptions (Details) - The 2019 Stock Plan [Member] - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Dividend-yield	0%	0%
Risk-free interest rate	3.93%	3.86%
Expected volatility	115.42%	124.62%
Expected life (years) (Year)	5 years 9 months 21 days	7 years
Market value per share on grant date (in dollars per share)	$ 3.1	$ 3.6
Fair value per option on grant date (in dollars per share)	$ 2.65	$ 3.29

Note 11 - Warrants (Details Tex

Note 11 - Warrants (Details Textual) - $ / shares shares in Thousands	Sep. 30, 2024	Jul. 01, 2024	Dec. 31, 2023	Jan. 09, 2012
Warrants and Rights Outstanding, Term (Year)	5 years 10 days
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 11.7		$ 11.7
Warrants in Connection With Subordinated Notes [Member] \| AAFK [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		113
Warrants and Rights Outstanding, Term (Year)		2 years		2 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.01		$ 0.01

Note 11 - Warrants - Schedule o

Note 11 - Warrants - Schedule of Warrants or Rights (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Outstanding, warrants (in shares) \| shares	530
Outstanding, Weighted - Average Exercise Price (in dollars per share) \| $ / shares	$ 11.7
Granted, warrants (in shares) \| shares	226
Granted, Weighted - Average Exercise Price (in dollars per share) \| $ / shares	$ 0.01
Exercised, warrants (in shares) \| shares	(226)
Exercised, Weighted - Average Exercise Price (in dollars per share) \| $ / shares	$ 0.01
Outstanding, warrants (in shares) \| shares	530
Outstanding, Weighted - Average Exercise Price (in dollars per share) \| $ / shares	$ 11.7
Outstanding, Average Remaining Term in Years (Year)	5 years 10 days

Note 11 - Warrants - Fair Value

Note 11 - Warrants - Fair Value Assumptions (Details)	Sep. 30, 2024 $ / shares yr	Sep. 30, 2023 $ / shares yr
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0	0
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0.045	0.038
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	0.9985	1.176
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input \| yr	2	4.63
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	0.01	1.18
Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input	4.05	4.11
Fair Value per Warrant on Grant Date [Member]
Warrants and Rights Outstanding, Measurement Input	4.04	3.97

Note 12 - Agreements (Details T

Note 12 - Agreements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jul. 01, 2022
Marketing Expense	$ 700	$ 800	$ 1,900	$ 700
Shipping and Handling Costs	1,100	700	2,600	900
Oil and Gas, Result of Operation, Transportation Cost	1,500	$ 1,400	4,400	$ 1,800
Forward Sales Commitments [Member]
Other Commitment	0		0
Operating Agreement with Gemini Edibles and Fats India Private Limited [Member]
Debt Agreement, Maximum Borrowing Capacity						$ 12,700
Debt Instrument, Interest Rate, Stated Percentage						18%
Accounts Payable	$ 100		$ 100		$ 500

Note 12 - Agreements - Schedule

Note 12 - Agreements - Schedule of Working Capital Agreement Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Revenues	$ 81,441	$ 68,690	$ 220,636	$ 115,953
Accounts payable	37,254		37,254		$ 32,132
J.D. Heiskell [Member]
Accounts receivable	19		19		1,073
Accounts payable	124		124		$ 1,207
J.D. Heiskell [Member] \| Ethanol Sales [Member]
Revenues	32,812	36,375	87,635	45,388
J.D. Heiskell [Member] \| Wet Distiller's Grains Sales [Member]
Revenues	8,961	9,427	27,476	11,980
J.D. Heiskell [Member] \| Corn Oil Sales [Member]
Revenues	1,746	1,487	4,199	1,613
J.D. Heiskell [Member] \| CDS Sales [Member]
Revenues	24	9	49	62
J.D. Heiskell [Member] \| Corn Purchases [Member]
Corn purchases	$ 33,170	$ 37,030	$ 97,489	$ 48,029

Note 13 - Segment Information_2

Note 13 - Segment Information (Details Textual) gal in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024 gal	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Number of Reportable Segments	3
California Ethanol [Member]
GallonPerYear (Gallon)	65
California Ethanol [Member] \| Customer Concentration Risk [Member] \| Revenue, Segment Benchmark [Member] \| Ethanol Sales, Wet Distillers Grain and Corn Oil Sales [Member]
Number of Major Customers	1	1	1	1
Concentration Risk, Percentage	97%	99.70%	98.60%	99.70%
India Biodiesel [Member]
GallonPerYear (Gallon)	60
India Biodiesel [Member] \| Customer Concentration Risk [Member] \| Revenue, Segment Benchmark [Member] \| Biodiesel Sales [Member] \| Customer One [Member]
Concentration Risk, Percentage	40%	42%	41%	43%
India Biodiesel [Member] \| Customer Concentration Risk [Member] \| Revenue, Segment Benchmark [Member] \| Biodiesel Sales [Member] \| Customer Two [Member]
Concentration Risk, Percentage	29%	35%	33%	28%
India Biodiesel [Member] \| Customer Concentration Risk [Member] \| Revenue, Segment Benchmark [Member] \| Biodiesel Sales [Member] \| Customer Three [Member]
Concentration Risk, Percentage	28%	19%	21%	24%

Note 13 - Segment Information -

Note 13 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues	$ 81,441	$ 68,690	$ 220,636	$ 115,953
Gross profit	3,878	492	1,460	1,153
Interest expense including amortization of debt fees	11,747	10,182	33,984	28,858
Accretion and other expenses of Series A preferred units	3,267	7,739	10,055	20,188
Income tax expense (benefit)	274	(55,308)	1,537	(54,490)
Capital expenditures	4,490	8,787	13,470	18,595
Depreciation	2,274	1,747	6,121	5,208
Loss on asset disposals			3,644	0
California Ethanol [Member]
Revenues	44,934	47,439	121,155	59,246
Gross profit	85	(1,473)	(9,494)	(3,807)
Interest expense including amortization of debt fees	7,911	6,729	22,807	18,499
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense (benefit)	0	0	0	0
Capital expenditures	154	1,363	584	2,423
Depreciation	1,111	960	3,120	3,029
Loss on asset disposals			3,644
California Dairy Renewable Natural Gas [Member]
Revenues	4,250	1,107	9,640	1,523
Gross profit	1,897	(807)	3,971	(2,644)
Interest expense including amortization of debt fees	808	620	2,174	1,841
Accretion and other expenses of Series A preferred units	3,267	7,739	10,055	20,188
Income tax expense (benefit)	0	(55,164)	36	(55,151)
Capital expenditures	3,762	6,819	10,911	14,622
Depreciation	866	598	2,206	1,578
Loss on asset disposals			0
India Biodiesel [Member]
Revenues	32,257	20,144	89,841	55,184
Gross profit	1,896	2,772	6,983	7,604
Interest expense including amortization of debt fees	30	19	659	313
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense (benefit)	274	(145)	1,501	653
Capital expenditures	257	372	575	523
Depreciation	241	158	629	470
Loss on asset disposals			0
Other Operating Segment [Member]
Revenues	0	0	0	0
Gross profit	0	0	0	0
Interest expense including amortization of debt fees	2,998	2,814	8,344	8,205
Accretion and other expenses of Series A preferred units	0	0	0	0
Income tax expense (benefit)	0	1	0	8
Capital expenditures	317	233	1,400	1,027
Depreciation	$ 56	$ 31	166	$ 131
Loss on asset disposals			$ 0

Note 13 - Segment Information_3

Note 13 - Segment Information - Reconciliation of Assets from Segments (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets	$ 247,425	$ 243,406
California Ethanol [Member]
Assets	57,060	67,991
California Dairy Renewable Natural Gas [Member]
Assets	110,975	92,794
India Biodiesel [Member]
Assets	40,116	34,769
Other Operating Segment [Member]
Assets	$ 39,274	$ 47,852

Note 14 - Related Party Trans_2

Note 14 - Related Party Transactions (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Employment Agreements and Expense Reimbursements [Member] \| Mr. McAfee [Member]
Related Party Transaction, Amounts of Transaction	$ 1
Various Board Members [Member]
Share-Based Payment Arrangement, Expense	0.1	$ 0.1	$ 0.3	$ 0.3
Various Board Members [Member] \| Board Compensation Fees [Member]
Related Party Transaction, Amounts of Transaction	$ 0.3				$ 0.3

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) $ in Millions	Nov. 06, 2024 USD ($)
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Prime Rate [Member]
PUPA Seventh Amendment [Member] \| Subsequent Event [Member]
Preferred Units Issued Value	$ 115.5
PUPA Seventh Amendment [Member] \| Subsequent Event [Member] \| Credit Agreement [Member]
Debt Instrument, Basis Spread on Variable Rate	10%
Debt Instrument, Interest Rate, Stated Percentage	16%